See the DrugPatentWatch profile for cosentyx

There is limited information available to directly answer your question regarding the impact of decreasing Cosentyx dosage on disease worsening. However, I can provide some context based on the available information.

Cosentyx, also known as secukinumab, is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a biologic drug that works by targeting and blocking a specific protein in the body, interleukin-17A, which is involved in inflammation [1].

When it comes to adjusting the dosage of Cosentyx, it is essential to follow the prescribing information and consult with a healthcare professional [1]. Any changes to the medication regimen, including dosage adjustments, should be made under the guidance of a healthcare provider, as they can assess the individual's response to treatment and potential risks [1].

Decreasing the dosage of Cosentyx without medical supervision may lead to suboptimal disease control or disease flare-ups [1]. This is because the drug's effectiveness in managing the underlying condition is closely tied to maintaining a consistent level of the medication in the body [1].

In summary, while there is no direct information available on whether disease worsens if Cosentyx dosage is decreased, it is generally not recommended to adjust the dosage without consulting a healthcare professional. Doing so may lead to suboptimal disease control or disease flares [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Secukinumab - DrugPatentWatch. Retrieved from https://www.drugpatentwatch.com/drugs/secukinumab